医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2015年
34期
83-84
,共2页
肺癌%COX-2%川芎嗪%侵袭%转移
肺癌%COX-2%川芎嗪%侵襲%轉移
폐암%COX-2%천궁진%침습%전이
Lung cancer%COX-2%Ligustrazine%Invasion%Metastasis
目的探讨COX-2介导川芎嗪抑制肺癌A549细胞侵袭转移的应用效果。方法对照组根据肺癌患者实际情况给予常规治疗措施;研究组在常规治疗基础上加用川芎嗪。记录两组肺癌患者治疗效果及随访1年复发转移率,将所得数据经专业分析(统计学)后获得结论。结果研究组临床总有效率(80.00%)显著高于对照组(临床总有效率55.00%)(<0.05);研究组疾病复发转移率(10.00%)显著低于对照组(疾病复发转移率30.00%)(<0.05)。结论川芎嗪可通过抑制肺癌A549细胞中COX-2表达获得满意的肺癌治疗效果,有利于降低肺癌侵袭及转移发生率,提高肺癌患者生活质量及生命安全。
目的探討COX-2介導川芎嗪抑製肺癌A549細胞侵襲轉移的應用效果。方法對照組根據肺癌患者實際情況給予常規治療措施;研究組在常規治療基礎上加用川芎嗪。記錄兩組肺癌患者治療效果及隨訪1年複髮轉移率,將所得數據經專業分析(統計學)後穫得結論。結果研究組臨床總有效率(80.00%)顯著高于對照組(臨床總有效率55.00%)(<0.05);研究組疾病複髮轉移率(10.00%)顯著低于對照組(疾病複髮轉移率30.00%)(<0.05)。結論川芎嗪可通過抑製肺癌A549細胞中COX-2錶達穫得滿意的肺癌治療效果,有利于降低肺癌侵襲及轉移髮生率,提高肺癌患者生活質量及生命安全。
목적탐토COX-2개도천궁진억제폐암A549세포침습전이적응용효과。방법대조조근거폐암환자실제정황급여상규치료조시;연구조재상규치료기출상가용천궁진。기록량조폐암환자치료효과급수방1년복발전이솔,장소득수거경전업분석(통계학)후획득결론。결과연구조림상총유효솔(80.00%)현저고우대조조(림상총유효솔55.00%)(<0.05);연구조질병복발전이솔(10.00%)현저저우대조조(질병복발전이솔30.00%)(<0.05)。결론천궁진가통과억제폐암A549세포중COX-2표체획득만의적폐암치료효과,유리우강저폐암침습급전이발생솔,제고폐암환자생활질량급생명안전。
Objective To explore the application ef ect of COX-2 mediated inhibition of lung cancer A549 cel s on the invasion and metastasis.Methods The control group,according to the actual situation of lung cancer patients received routine treatment;the study group on the basis of conventional therapy plus ligustrazine.Records of patients with lung cancer and the therapeutic ef ect of two groups were fol owed up for 1 year recur ence rate,the obtained data by professional analysis (Statistics)to obtain the conclusion.Results The clinical total ef ective rate in the study group (80%)was significantly higher than that of the control group(the total ef ective rate was 55%( <0.05);The research group,disease recur ence and metastasis rate (10%) was significantly lower than the control group (disease recur ence and metastasis rate was 30% ( <0.05) .Conclusion Ligustrazine can inhibit lung cancer treatment ef ect of lung cancer cel A549 and COX-2 expression in the satisfactory,to reduce the incidence of invasion and metastasis of lung cancer,improve the quality of life of patients with lung cancer and life safety.